3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gynecologic
319
Gastrointestinal
44
Breast
33
Genitourinary
24
Thoracic
21
Dermatologic
17
Sarcoma
14
Head & Neck
13
Other hematologic neoplasm
8
Lymphoid
8
CNS
7
Other
6
Plasma cell
4
Classical hematology
3
NET
2
Myeloid
2
Endocrine
2
Other solid neoplasm
1
Other neoplasm
1
Conditions
Precancerous Conditions
48
Uterine Cervical Neoplasms
7
Uterine Cervical Dysplasia
6
Colorectal Neoplasms
6
Papillomavirus Infections
5
Lung Neoplasms
5
Colonic Neoplasms
5
Neoplasms
4
Multiple Myeloma
4
Monoclonal Gammopathy of Undetermined Significance
4
Esophageal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Lymphoma
3
HIV Infections
3
Carcinoma, Intraductal, Noninfiltrating
3
Breast Neoplasms
3
Waldenstrom Macroglobulinemia
2
Secondary Malignant Neoplasm of Liver
2
Rare Malignant Neoplasm
2
Prostatic Neoplasms
2
Pancreatic Malignant Neoplasm Primary
2
Oropharyngeal Neoplasms
2
Neoplasms, Plasma Cell
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Mouth Neoplasms
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Endometrial Neoplasms
×
Other neoplasm
×
Clear all
NCT07544680
2026-04-22
ENVISION
Exact Sciences Corporation
Recruiting
4,200 enrolled